This article summarizes the most significant insider buying and selling activities reported on Friday for US stocks.
Top Insider Buys:
Marvell Technology, Inc. (NASDAQ:MRVL): Brad W. Buss, a director at Marvell Technology, Inc., acquired 3,000 shares of the company’s common stock on March 7, 2025. The purchase, totaling approximately $207,000, was made at a weighted average price of $69 per share. This acquisition brings Buss’s total holdings to 87,113 shares. The timing of the purchase is notable as the stock has declined over 22% in the past week, with technical indicators suggesting oversold conditions. InvestingPro data also shows that 19 analysts have recently revised their earnings expectations upward for Marvell Technology, with the company expected to return to profitability this year.
Tenaya Therapeutics , Inc. (NASDAQ:TNYA): David Goeddel, a director and significant stakeholder of Tenaya Therapeutics, Inc., made a substantial investment in the company’s stock amid significant price volatility. Goeddel purchased 35,714,284 shares at $0.70 per share on March 5, 2025, for a total investment of approximately $24.9 million. This acquisition was part of an underwritten public offering that included common stock, Series A warrants, and Series B warrants. Despite the recent 55% decline in stock price, InvestingPro data indicates that Tenaya maintains a strong liquidity position with more cash than debt and a current ratio of 5.27x.
JELD-WEN Holding, Inc. (NYSE:JELD): Turtle Creek Asset Management Inc., a significant shareholder in JELD-WEN Holding, Inc., increased its stake in the company with purchases totaling approximately $774,036 over March 5 and 6, 2025. The stock has shown a strong 12% gain over the past week, though it remains below its 52-week high. InvestingPro data reveals that management has been actively buying back shares despite the company’s significant debt burden.
BlackRock ESG Capital Allocation Term Trust (NYSE:ECAT): BlackRock Inc. (NYSE:BLK) increased its holdings in the BlackRock ESG Capital Allocation Term Trust by acquiring 79,600 common shares at a weighted average price of $16.50 each, for a total transaction value of approximately $1.31 million. This brings BlackRock’s direct ownership in the trust to 238,800 shares. The trust offers an attractive dividend yield of 22.22% and has maintained a consistent dividend increase for four consecutive years, according to InvestingPro data.
Janux Therapeutics , Inc. (NASDAQ:JANX): RA Capital Management, L.P., a significant shareholder in Janux Therapeutics, Inc., increased its stake by purchasing 824,041 shares between March 5 and 7, 2025. The total investment amounted to approximately $25.3 million, with share prices ranging from $30.56 to $31.30. InvestingPro data shows the stock trading near its 52-week low, with a market capitalization of $1.83 billion. Janux maintains strong financial health with a current ratio of 59.21 and holds more cash than debt on its balance sheet.
Top Insider Sells:
Natera, Inc. (NASDAQ:NTRA): Steven Chapman, CEO and President of Natera, Inc., sold 87,272 shares of the company’s common stock on March 5, 2025. The sales were conducted at prices ranging from $141.91 to $145.42 per share, totaling approximately $12.5 million. The stock has delivered a 57.94% return over the past year, according to InvestingPro data. Following these transactions, Chapman retains ownership of 203,354 shares of Natera stock.
BeiGene (NASDAQ:ONC), Ltd. (NASDAQ:BGNE): John Oyler, CEO of BeiGene, Ltd., sold American Depositary Shares valued at approximately $14.6 million on March 7, 2025. The transaction prices ranged from $246.03 to $256.10 per share. Oyler also exercised options to acquire 1,470,417 ordinary shares at a price of $0.50 per share. InvestingPro forecasts show promising revenue growth of 56% for FY2025 for BeiGene.
Penumbra Inc . (NYSE:PEN): Adam Elsesser, CEO and President of Penumbra Inc., sold 66,600 shares on March 5, 2025, at prices ranging from $281.14 to $286.57 per share, totaling approximately $17.47 million. Elsesser also exercised stock options to acquire 72,976 shares at a price of $30.00 per share.
BeiGene, Ltd. (NASDAQ:BGNE): Wu Xiaobin, President, COO & GM China of BeiGene, Ltd., sold 51,921 American Depositary Shares for approximately $13.6 million on March 5. Wu also exercised options to acquire 655,973 ADS at prices between $119.96 and $169.65, totaling approximately $6.6 million.
Enphase Energy, Inc. (NASDAQ:ENPH): Thurman Rodgers, a director at Enphase Energy, Inc., sold 100,000 shares at an average price of $61.257, amounting to a total transaction value of approximately $6.13 million on March 7. The sale comes as Enphase’s stock has declined over 52% in the past year, with InvestingPro data showing the company currently trades at a P/E ratio of 80.5x.
Investors should stay tuned to insider buying and selling activities as they can provide valuable insights into a company’s prospects. While insider transactions alone should not be the sole basis for investment decisions, they can offer additional context when combined with fundamental and technical analysis. It’s important to consider the overall market conditions, company performance, and individual circumstances of the insiders when interpreting these transactions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.